OBJECTIVE	This study compared the clinical toxicity and hematological effects of i.p. and s.c. administration of fms-like tyrosine kinase-3-ligand ( Flt3-L ; Amgen , Thousand Oaks , CA ) , a truncated glycoprotein that increases dendritic cells ( DCs ) and monocytes .\